Report cover image

At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023

Published Jun 22, 2023
Length 142 Pages
SKU # KLI18014720

Description

At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023


This new Kalorama Information report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023, examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods.

Meanwhile, the global Home IVD testing market is a growing market with much potential. The Home Collection IVD testing market is comprised of testing kits that are obtained from the local pharmacy or internet and sent to the patient's home. The patient collects the specimen, puts it into a collection container and sends it to the laboratory for testing. Results are sent back to the patient and/or referring physician.

This report covers the At-Home and Home testing markets by segmenting them into several broad areas including:
  • Cholesterol
  • Drugs of Abuse
  • Fecal Occult Blood
  • Glucose/ HbA1c including CGM
  • Infectious Disease
* COVID-19 / + Flu + RSV
* HIV
  • Pregnancy and Fertility
  • Rapid Coagulation
  • Genetic (excluding ancestry genetic testing)
The base year for data featured in the report was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, EMEA, Asia-Pacific and Rest of World for 2019-2022. The forecasted market analysis for 2022-2027 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

142 Pages
    • Industry at a Glance
    • Scope and Methodology
    • Size and Growth of the Market
    • Key Issues and Trends Affecting the Market
    • Competitive Outlook
    • Conclusion Highlights
    • Overview
    • Issues and Trends
    • Genetics
    • Home Collection
    • Introduction
    • At-Home IVD Test Market by Test Type
    • At-Home IVD Tests Market by Sample Type
    • Introduction
    • Home Collection IVD Tests by Test Type
    • Home Collection Tests by Sample Type
    • 23andMe, Inc
    • Abbott Diagnostics
    • AccessBio, Inc.
    • ACON Laboratories, Inc.
    • ARKRAY, Inc.
    • Ascensia Diabetes Care Holdings AG
    • Atomo Diagnostics
    • Becton-Dickinson
    • binx health
    • Biomerica, Inc.
    • Biosynex SA
    • BTNX Inc.
    • Church & Dwight Co. Inc
    • Color Health, Inc.
    • Cue Health
    • Dexcom, Inc.
    • EasyDNA
    • Everlywell
    • Exact Sciences
    • First Check Diagnostics LLC
    • GlysBy diagnostics
    • Helena Laboratories
    • Hemosure, Inc.
    • LifeScan, Inc
    • Medichecks.com Ltd.
    • Myriad Genetics, Inc.
    • OraSure Technologies, Inc.
    • Polymedco, Inc
    • Preventis GmbH
    • Prima Lab SA
    • QuidelOrtho Corporation
    • Roche Diagnostic Corporation
    • Siemens Healthineers GmbH
    • Swiss Precision Diagnostics GmbH
    • Trividia Health
    • VedaLab
    • Market Overview
    • Market Segment by Test Type
    • Market by Distribution
    • Market by Region
    • Competitive Analysis
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.